Skip to main content
Catherine Marshall, MD, Oncology, Baltimore, MD, Johns Hopkins Hospital

CatherineHandyMarshallMDMPH

Oncology Baltimore, MD

Hematologic Oncology

Assistant Professor

Dr. Marshall is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Marshall's full profile

Already have an account?

  • Office

    600 N. Wolfe Street
    Harvey Building, Room 808
    Baltimore, MD 21287
    Phone+1 410-955-7911
    Fax+1 410-955-0374
  • Is this information wrong?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Medical Oncology, 2017
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2012 - 2015
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2012

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2021 - 2024
  • MD State Medical License
    MD State Medical License 2015 - 2024
  • PA State Medical License
    PA State Medical License 2020 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Cardiorespiratory fitness and incident lung and colon cancer: FIT-Cancer Cohort. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • Prevalence of homologous recombination deficiency (HRD) mutations in localized prostate cancer according to Gleason grade: Implications for neoadjuvant clinical trial ... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • ASCO 2022 Highlights
    ASCO 2022 HighlightsJuly 27th, 2022
  • Editor’s Talk: Triplet Versus Doublet Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Editor’s Talk: Triplet Versus Doublet Therapy in Metastatic Hormone-Sensitive Prostate CancerJune 24th, 2022
  • Improving Enrollment for Prostate Cancer Clinical Trials
    Improving Enrollment for Prostate Cancer Clinical TrialsMay 27th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations